Christy Chuang-Stein

发表

Recent Advancements in the Analysis and Presentation of Safety Data

Christy Chuang-Stein, Vu Le, William T. Chen, 2001 .

Sample Size Reestimation: A Review and Recommendations

Paul Gallo, Keaven Anderson, Christy Chuang-Stein, 2006 .

Safety Analysis in Controlled Clinical Trials

Christy Chuang-Stein, C. Chuang-Stein, 1998 .

Overview of Benefit–Risk Evaluation Methods: A Spectrum from Qualitative to Quantitative

Guochen Song, George Quartey, Christy Chuang-Stein, 2017 .

The Impact of Parameterization on the Interpretation of the Main-Effect Term in the Presence of an Interaction

Christy Chuang-Stein, Donald M. Tong, 1996 .

Pharmaceutical Statistics Using SAS: A Practical Guide

Alex Dmitrienko, Ralph B. D'Agostino, Christy Chuang-Stein, 2007 .

An Application of the Beta-Binomial Model to Combine and Monitor Medical Event Rates in Clinical Trials

Christy Chuang-Stein, C. Chuang-Stein, 1993 .

Adaptive Dose-Response Studies

Paul Gallo, Brenda Gaydos, Michael Krams, 2006 .

Discussion of “Some Controversial Multiple Testing Problems in Regulatory Applications”

Alex Dmitrienko, Christy Chuang-Stein, Walter W. Offen, 2009 .

Biopharmaceutical Research, Statistics in

Christy Chuang-Stein, C. Chuang-Stein, 2011, International Encyclopedia of Statistical Science.

Tutorial in Biostatistics A review of tests for detecting a monotone dose–response relationship with ordinal response data

Alan Agresti, Christy Chuang-Stein, A. Agresti, 1997 .

Summarizing Laboratory Data with Different Reference Ranges in Multi-Center Clinical Trials

Christy Chuang-Stein, C. Chuang-Stein, 1992 .